The FDA denied two Freedom of Information Act requests from Juul for the “scientific disciplinary reviews” used to reject marketing authorization for Juul’s products, the company alleged Tuesday in a complaint filed in the US District Court for the District of Columbia.
The filing marks the latest move in the standoff between Juul and the FDA, which in July administratively suspended its ban on Juul products after determining there were additional scientific issues it needed ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
